Silgan控股

Silgan Holdings: Citigroup raises Buy rating, PT raised to $56 from $47.

Silgan Holdings: Wells Fargo maintains Overweight, PT raised to $55 from $52.

Silgan Holdings's 15min chart sees MACD Death Cross, KDJ Death Cross.

Silgan Holdings: RBC Capital Raises PT to $49 from $43, Maintains Sector Perform.

Silgan Holdings: UBS raises PT to $50, maintains Neutral rating.

Catalyst<ul> <li>Recent Bearish Engulfing signals on December 23 2025 and January 7 2026 indicate some bullish bias potential for SLGN.</li></ul>Risk<ul> <li>Technical analysis shows bearish signals are dominant with four negative indicators versus only one bullish signal.</li> <li>Fund flows across all order sizes remain negative indicating ongoing outflows and weak investor demand for SLGN.</li> <li>Fundamental factors highlight concerns with profit margins and cash flow relative to operating revenue.</li></ul>

Key Factors

SLGN's Q4 earnings beat was driven by record performance in its Dispensing and Specialty Closures segment, marking a strategic operational pivot.

SLGN News